Live feed16:05:00·1040dPRReleasevia QuantisnowRezolute to Initiate a Pivotal Phase 3 Study of RZ358 in Participants 3 Months of Age and Older with Congenital HyperinsulinismByQuantisnow·Wall Street's wire, on your screen.RZLT· Rezolute Inc.Health Care
